Filed before 2025Filed 20 March 2019
Orbus Therapeutics, Inc. has sold $18.5M so far
Orbus Therapeutics, Inc., a biotech company based in Palo Alto, CA, has sold $18.5M so far in its equity round, according to a filing dated 20 March 2019.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 20 March 2019
- First filed
- 15 August 2017
- Round
- Equity round (amended filing)
- Amount sold
- $18.5M
- Offering size
- $39.5M
- Investors so far
- 16
- Based in
- Palo Alto, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 74% of the 1,781 tracked raises with an amount filed in 2019, and than 65% of the 146 in biotech.
Orbus Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 11 Aug 2020 | New filing | $10M | Another raise |
| 20 Mar 2019 | Amended filing | $18.5M | This raise |
| 15 Aug 2017 | New filing | $12.5M | This raise |
| 21 Aug 2015 | New filing | $18M | Another raise |
More with Longitude on the board
- Infinant Health, Inc.$39.2M
- Veradermics, Inc$135M
- CuraSen Therapeutics, Inc.$5.79M
- Zenas BioPharma, Inc.$200M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.